Board of Directors 2020-2022 | Hellenic Bioscientific Association of the USA
Petros YPSILANTIS | Professor (Associate) | Assoc. Professor Exp Surgery, DVM, PhD | Democritus University of Thrace, Komotiní | DUTH | School of Medicine | Research profile
Konstantinos KOSTIKAS | Head of Department | MD, PhD, FCCP | University of Ioannina, Ioánnina | UOI | Respiratory Medicine | Research profile
Ioannis Kottakis MD,PhD,FCCP – Clinical Development and Medical Affairs Consultant – Helvetic Payroll | LinkedIn
KoreaMed Synapse
Board of Directors 2020-2022 | Hellenic Bioscientific Association of the USA
80+ "Ioannis M.d" profiles | LinkedIn
Ioannis Kottakis email address & phone number | Helvetic Payroll Clinical Development and Medical Affairs Consultant contact information - RocketReach
Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: Results o
Ioannis Kottakis MD,PhD,FCCP – Clinical Development and Medical Affairs Consultant – Helvetic Payroll | LinkedIn
Dimitrios KALKANIS | Hellenic Air Force, Athens | 251 Airforce General Hospital | Research profile
Ioannis Kottakis email address & phone number | Helvetic Payroll Clinical Development and Medical Affairs Consultant contact information - RocketReach
Dr. Stephen Naber, MD – Boston, MA | Pathology
CONGRESS GUIDE
80+ "Ioannis M.d" profiles | LinkedIn
Dr. Stephen Naber, MD – Boston, MA | Pathology
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease - IOS Press
Asthma patients are Still Fighting for Breath | European Respiratory Society
Ioannis Kottakis MD,PhD,FCCP – Clinical Development and Medical Affairs Consultant – Helvetic Payroll | LinkedIn
Use of interrupter technique in assessment of bronchial responsiveness in normal subjects | BMC Pulmonary Medicine | Full Text
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease
Board of Directors 2020-2022 | Hellenic Bioscientific Association of the USA
Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase II
Dr. Stephen Naber, MD – Boston, MA | Pathology
Michael HUMPHRIES | Head of Department | Development | Research profile
